Bank of New York Mellon Corp - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 43 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2019$20,000
+53.8%
24,590
+68.2%
0.00%
Q4 2018$13,000
-53.6%
14,6180.0%0.00%
Q3 2018$28,000
+16.7%
14,618
-0.0%
0.00%
Q2 2018$24,000
-17.2%
14,619
-3.6%
0.00%
Q1 2018$29,000
+3.6%
15,171
+3.8%
0.00%
Q4 2017$28,000
+27.3%
14,619
-16.9%
0.00%
Q3 2017$22,000
-31.2%
17,585
-30.8%
0.00%
Q2 2017$32,000
-37.3%
25,428
-39.8%
0.00%
Q1 2017$51,000
-34.6%
42,247
+6.5%
0.00%
Q4 2016$78,000
-56.4%
39,670
-21.7%
0.00%
Q3 2016$179,000
-22.8%
50,670
-21.9%
0.00%
Q2 2016$232,000
-35.2%
64,873
-12.3%
0.00%
Q1 2016$358,000
+3.2%
73,991
+25.7%
0.00%
Q4 2015$347,000
+50.9%
58,864
+51.7%
0.00%
Q3 2015$230,000
-47.8%
38,798
+19.7%
0.00%
Q2 2015$441,000
+137.1%
32,411
+123.0%
0.00%
Q1 2015$186,00014,5320.00%
Other shareholders

There were no reported owners of SECOND SIGHT MED PRODS INC in Q1 2015.

NameSharesValueWeighting ↓
View complete list of SECOND SIGHT MED PRODS INC shareholders